Evidence map›Paper›PMID 38517520›Full record

ReviewDermatologie (Heidelberg, Germany)2024

[Benefits of participatory involvement of patients in the development of a dermatological treatment app-A report from the practice].

Anne Koopmann, Anna Maria Pfeifer, Lara Schweickart, Nathalie Biniaminov, Valentin Haas, Philipp Marquardt, Astrid Gößwein, Christopher Czaban, Sergey Biniaminov, Mara Blauth and 5 more

Open access · hybridAbstract readEnglish AbstractReview
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Anne KoopmannKlinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit Mannheim, Universität Heidelberg, Mannheim, Deutschland.
Anna Maria PfeiferKlinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit Mannheim, Universität Heidelberg, Mannheim, Deutschland.
Lara SchweickartFZI Forschungszentrum Informatik, Karlsruhe, Deutschland.
Nathalie BiniaminovHS Analysis GmbH, Haid-Und-Neu-Str. 7, 76131, Karlsruhe, Deutschland.
Valentin HaasHS Analysis GmbH, Haid-Und-Neu-Str. 7, 76131, Karlsruhe, Deutschland.
Philipp MarquardtHS Analysis GmbH, Haid-Und-Neu-Str. 7, 76131, Karlsruhe, Deutschland.
Astrid GößweinDataSpark GmbH, Frankfurt, Deutschland.
Christopher CzabanDataSpark GmbH, Frankfurt, Deutschland.
Sergey BiniaminovHS Analysis GmbH, Haid-Und-Neu-Str. 7, 76131, Karlsruhe, Deutschland.
Mara BlauthKlinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Deutschland.
Caroline GlatzelKlinik für Dermatologie und Venerologie, Universitätsklinikum Würzburg, Haus D8, Josef-Schneider-Str. 2, 97080, Würzburg, Deutschland.
Christoph ZimmermannFZI Forschungszentrum Informatik, Karlsruhe, Deutschland.
Wilhelm StorkKarlsruher Institut für Technologie, Karlsruhe, Deutschland.
Victor OlsavszkyKlinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Deutschland.
Astrid SchmiederKlinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Deutschland. Schmieder_A@ukw.de.
Central Institute of Mental Health · DEFZI Research Center for Information Technology · DEUniversity Hospital Heidelberg · DEHeidelberg University · DEKarlsruhe Institute of Technology · DEUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 2% of the German population suffer from psoriasis. HybridVITA has developed a mobile application (app) that enables psoriasis patients to independently document the progression of the disease and the current psychological stress at home. The HybridVITA app was created in close collaboration with user groups to ensure optimal adaptation to their needs. Two interactive workshops were held with the user groups and the technical developers of the app as a core element of the developmental process. The workshops identified the needs and suggestions for improvement of the various user groups and formulated user stories for the further development of the app using the Scrum method. The participatory approach of the workshop enabled the project team to gather valuable practical knowledge at an early stage of development. The team's awareness of potential obstacles during the early stages of the project enabled them to proactively identify and address these issues prior to implementing the app in dermatological care. We are confident that a patient-centered and participatory approach to health app development can provide valuable insights for developers.

Indexed as

Mobile ApplicationsPatient ParticipationPsoriasisDermatologyGermanyHumansArtificial intelligenceMachine learningPatient-centered carePsoriasisStress, psychological

Identifiers

PMID38517520
PMCPMC11224106
OpenAlexW4393088084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.